Orion Pharma (UK) Limited

Oaklea Court, 22 Park Street, Newbury, Berkshire, RG14 1EA
Telephone: +44 (0)1635 520 300
Fax: +44 (0)1635 580 180
Medical Information e-mail: medicalinformation@orionpharma.com
Out of Hours Telephone: +44 (0)1635 520 300
Patient Information Leaflet last updated on the eMC: 16/09/2009
PIL Comtess 200mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to MA holder contact details
Updated on 20/04/2009 and displayed until 16/09/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 31/05/2007 and displayed until 20/04/2009
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to side-effects
  • Change to storage instructions
  • Change to Further Information section
Updated on 29/11/2006 and displayed until 31/05/2007
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to date of revision
Updated on 25/04/2005 and displayed until 29/11/2006
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/12/2003 and displayed until 25/04/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 22/11/2002 and displayed until 08/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 23/09/2002 and displayed until 22/11/2002
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   entacapone


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk